Concepedia

Harshini Chinnasamy

HC

Statistics

Publications

7

Citations

2.2K

H-Index

7

Active since

2016

Affiliations

Stanford University(Current)

National Institutes of Health

Center for Cancer Research

City Of Hope National Medical Center

Dana-Farber Cancer Institute

Harshini Chinnasamy is an author at Stanford University specializing in molecular diagnostics, medicine, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2016–2024

7

Publications

7

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

Nikolaos Zacharakis, Harshini Chinnasamy, Mary A. Black et al. · Nature Medicine · 2018 · 757 citations

, , +13

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 737 citations · Full text

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

Michelle Monje, Jasia Mahdi, Robbie G. Majzner et al. · Nature · 2024 · 123 citations · Full text

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

Matthew J. Frank, John H. Baird, Anne Marijn Kramer et al. · The Lancet · 2024 · 45 citations · Full text

1–5 of 7